-
CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to
#CARTs#CGTs#GMP working with#CDMOs...and if you don't know these acronyms, you should definitely check it out! https://www.ccrm.ca/cdmo_education_centre …#Biotechnology#STEMpic.twitter.com/aad829JLKi -


#countdown#Christmas#53Biologics Our#mission is to provide#services to different companies, from start-ups to large companies, as well as to other#CDMOs, to help their products to reach the market#pharma#biotecnology#biotech#microbiologypic.twitter.com/IvEvlubW46
-
What's the cost of selecting the right
#CRO? Make sure you are aware of all of the tests possible and contact us if you need help getting recommended CROs and#CDMOs! https://blog.rheosense.com/cros-cdmo -
We are so very proud to share the news about our
#FDA approval!! This achievement positions us at the level of the most distinguished#CDMOs in the world and represents a very important breakthrough in the history of 3P. https://www.3pbio.com/2019/09/18/3p-biopharmaceuticals-receives-fda-approval/ … pic.twitter.com/RfExhOFPxR
-
Pharma
#CDMOS: long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at#PBOACON19@PBOAssocpic.twitter.com/AM6hVZ8XHL
-
It's important for
#CDMOs to be fully transparent when it comes to audits to ensure the correct quality is achieved. Read more: https://bit.ly/2Fi7au7 via@OutsourcedPharm -
"Fear of innovation in the East will drive innovation in the West." Do Western CMOs need to 'up their game' to combat an increasingly Eastern-facing market? Read our latest article
https://bit.ly/2Z0t8JQ
#CMOs#CDMOs#pharma#pharmaceuticals#innovation#NCEspic.twitter.com/0hpijXCKK5 -
The value
#CROs and#CDMOs bring, especially smaller, focused biotechs can sometimes be overlooked. However, a strong symbiotic relationship between companies and their partners is critical to bring new therapies to market. Thanks@Louis_Garguilo!https://www.lifescienceleader.com/doc/i-outsource-therefore-i-exist-0001?vm_tId=2114446&user=57be9c65-5ff3-47de-870a-30bb98fe8e4b&vm_alias=I%2520Outsource,%2520Therefore%2520I%2520Exist&utm_source=mkt_LSL&utm_medium=email&utm_campaign=LSL_03-04-2019&utm_term=57be9c65-5ff3-47de-870a-30bb98fe8e4b&utm_content=I%2520Outsource,%2520Therefore%2520I%2520Exist&mkt_tok=eyJpIjoiT0dJNVltVXlaV1kxT0dGaiIsInQiOiIrWXJxVmN3ejM1c2lhM21tRkJVc1wvRHpJdm5tVFZwRThEY01YU0M4OUcwZ0N2UDB0dlJ3allUTExkeDJzaCt1UjNtaG5WTXdFbHNLV014UGtZbDdqeUNHMUF5ekZBRzRJOXpZdWZZMVJ5UE94cVhHRkpWbzVHWTBSUkkzdEYzajEifQ%253D%253D … -
Read a first-hand report by the
@Siegfried_Group about the#opportunities for Western#CDMOs in China https://twitter.com/CHEManager_EU/status/1069522909088092160 …
-
Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the
#CDMOs have started to feel real +ve traction.Prikaži ovu nit -
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
-
Discover insider information from a recent roundtable discussion about the use of
#CDMOs and what companies are looking for from them and much more. Download your copy here http://bit.ly/2uGKQZq pic.twitter.com/UR98IGwsCr
-
‘Lack of good CDMOs’ factor for Krystal’s $90m gene therapy plant https://buff.ly/2u9eTcv
#biotech#startups#CDMOs via@Xconomy -
Although pharmaceutical companies choose to
#outsource for different reasons, many businesses work with CROs, CMOs and#CDMOs because it can reduce the overall cost and risk of their project. Explore the other factors driving a surge in outsourcing here: https://bit.ly/32gaC1Z pic.twitter.com/U3fTaoXABL
-
"Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.” Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between
#CDMOs and#Pharma in@medicine_maker: https://bit.ly/2E6DcK1 pic.twitter.com/KSObEAxEMA
-
On 12 November we organise with
@biocat_en the workshop 'Technologies for improving bioavalilability of poorly water-soluble#drugs' by Dr A. Loxley, consultant of#ParticleSciences (@LZLifeSciHealth), one of the world's leading#CDMOs
https://bit.ly/31JnoFZ
Don't miss it!
pic.twitter.com/WPl44nAwmQ
-
.
@Cenmag interviewed Michel Lagarde, Executive VP of Thermo Fisher Scientific, about the challenges#CDMOs are facing as the pharma and#biotech markets rapidly grow.https://bit.ly/2Mq8Qqh -
The
#pharmaceuticalindustry continues to grow and is estimated at $1.5 trillion by 2021. An important driver is the trend to#outsource development and manufacturing to#CDMOs. We have asked executives working in this market to share their experiences. http://bit.ly/2Na7eTf pic.twitter.com/PgJ6CQFqg3
-
Supply chain digitization creates new revenue opportunities in the vaccine market via
@HPN_Online http://ow.ly/PFu130pBZyb#SupplyChain#HealthcareSupplyChain#Vaccines#PublicHealth#CDMOs -
Biopharma Supply Chains At Industry 4.0 https://www.outsourcedpharma.com/doc/biopharma-supply-chains-at-industry-0002 … "To get to a full digital dialogue, drug sponsors and
#CDMOs alike will need to muster their resources and usher in what the rest of the world already calls Industry 4.0."#pharma#biotech
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.